RT Journal Article
SR Electronic
T1 At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: post-collection acceptability of specimen collection process and patient confidence in specimens
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.10.20127845
DO 10.1101/2020.06.10.20127845
A1 Valentine-Graves, Mariah
A1 Hall, Eric
A1 Guest, Jodie
A1 Adam, Elizabeth
A1 Valencia, Rachel
A1 Hardee, Isabel
A1 Shinn, Katlin
A1 Sanchez, Travis
A1 Siegler, Aaron J
A1 Sullivan, Patrick
YR 2020
UL http://medrxiv.org/content/early/2020/06/12/2020.06.10.20127845.abstract
AB Background Options to increase the ease of testing for SARS-CoV-2 infection and immune response are needed. Self-collection of diagnostic specimens at home offers an avenue to allow people to test for SARS-CoV-2 infection or immune response without traveling to a clinic or laboratory. Before this study, survey respondents indicated willingness to self-collect specimens for COVID-related tests, but hypothetical willingness can differ from post-collection acceptability after participants collect specimens.Methods 153 US adults were enrolled in a study of the willingness and feasibility of patients to self-collect three diagnostic specimens (saliva, oropharyngeal swab (OPS) and dried blood spot (DBS) card) while observed by a clinician through a telehealth session. After the specimens were collected, 148 participants participated in a survey about the acceptability of the collection, packing and shipping process, and their confidence in the samples collected for COVID-related laboratory testing.Results A large majority of participants (>84%) reported that collecting, packing and shipping of saliva, OPS, and DBS specimens were acceptable. Nearly nine in 10 (87%) reported being confident or very confident that the specimens they collected were sufficient for laboratory analysis. There were no differences in acceptability for any specimen type, packing and shipping, or confidence in samples by gender, age, race/ethnicity, or educational level.Conclusions Self-collection of specimens for SARS-CoV-2 testing and preparing and shipping specimens for analysis were acceptable in a diverse group of US adults. Further refinement of materials and instructions to support self-collection of saliva, OPS and DBS specimens for COVID-related testing is needed.Trial registration No intervention was tested in this studyCompeting Interest StatementThe authors have declared no competing interest.Clinical Protocols https://publichealth.jmir.org/2020/2/e19054/ Funding StatementThis work was supported by the National Institutes of Health (3R01AI143875-02S1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Emory University IRB, Protocol 371All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon request to the authorsDBSDried blood spotOPSOropharyngeal swabPCRPolymerase chain reactionPPEPersonal protective equipment